Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 208

Sort by

Sort Order Select

Journal Articles

A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas

Laurence de Leval, Philippe Gaulard, Ahmet Dogan

Blood (2024) 144 (18): 1855–1872.

https://doi.org/10.1182/blood.2023021786

Published: 2024

Journal Articles

Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation

Blood blood.2024025563.

https://doi.org/10.1182/blood.2024025563

Published: 2024

Includes: Supplemental data

Journal Articles

The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma

Blood (2024) 144 (7): 771–783.

https://doi.org/10.1182/blood.2024024299

Published: 2024

Includes: Supplemental data

Journal Articles

Deep Learning for Morphology-Based, Bone Marrow Cell Classification

Shenghuan Sun, Jacob Cleave, Linlin Wang, Fabienne Lucas, Laura Brown, Jacob Spector, Leonardo Boiocchi, Jeeyeon Baik, Menglei Zhu, Orly Ardon, Chuanyi M. Lu, Ahmet Dogan, Dmitry Goldgof, Iain Carmichael, Sonam Prakash, Atul Butte, Gregory Mark Goldgof

Blood (2023) 142 (Supplement 1): 2841.

https://doi.org/10.1182/blood-2023-172654

Published: 2023

Journal Articles

Polytypic B-Cells, B-Cell Lymphoproliferative Disorders/Lymphomas, and Neoplastic T-Cells Divergently Differentiate from TET2 -/ DNMT3A -Mutated Clonal Hematopoiesis in Patients with Follicular Helper T-Cell Lymphomas/Lymphoproliferative Disorders

Natasha Lewis, Kseniya Petrova-Drus, Rohan Sardana, Qi Gao, Shenon Sethi, Wenbin Xiao, Mikhail Roshal, Jeeyeon Baik, Himanshu Bhurtel, Alison Moskowitz, Steven M. Horwitz, Ahmet Dogan

Blood (2023) 142 (Supplement 1): 849.

https://doi.org/10.1182/blood-2023-187320

Published: 2023

Journal Articles

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

N. Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D. Zelenetz, Gilles Salles, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6099.

https://doi.org/10.1182/blood-2023-185338

Published: 2023

Journal Articles

A Multicenter Phase 2 Trial of Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen) in Patients with Treatment-Naïve, TP53 -Mutant Mantle Cell Lymphoma

Blood (2023) 142 (Supplement 1): 738.

https://doi.org/10.1182/blood-2023-180069

Published: 2023

Journal Articles

Impact of Early Histological Transformation on Survival in Patients with Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 3023.

https://doi.org/10.1182/blood-2023-190325

Published: 2023

Journal Articles

Clinical Characteristics and Outcomes of Limited Stage High Grade B-Cell Lymphoma with MYC/BCL2 and/or BCL6 Rearrangements: A Single Center Experience

Blood (2023) 142 (Supplement 1): 3129.

https://doi.org/10.1182/blood-2023-173562

Published: 2023

Journal Articles

Cumulative Incidence of Myeloid Neoplasms in Patients with Nodal T-Follicular Helper Cell Lymphoma

Robert Stuver, Nivetha Ganesan, Ahmet Dogan, Zachary D. Epstein-Peterson, Paola Ghione, William Johnson, Natasha Lewis, Alison Moskowitz, Gunjan L. Shah, Michael Scordo, Wenbin Xiao, Steven M. Horwitz

Blood (2023) 142 (Supplement 1): 4438.

https://doi.org/10.1182/blood-2023-182272

Published: 2023

Journal Articles

Ruxolitinib Promotes Clinical Responses in Large Granular Lymphocytic Leukemia Via Suppression of JAK/STAT-Dependent Inflammatory Cascades

Blood (2023) 142 (Supplement 1): 183.

https://doi.org/10.1182/blood-2023-181922

Published: 2023

Journal Articles

Real-World Outcomes in Patients with Transformed Follicular Lymphoma Treated with CD19-Targeting CAR-T Therapy

Blood (2023) 142 (Supplement 1): 4888.

https://doi.org/10.1182/blood-2023-187379

Published: 2023

Journal Articles

Revealing Novel Mechanisms Underlying Inactivation of Tumor Suppressor Genes on Duplicated Chromosomes in Multiple Myeloma

Blood (2023) 142 (Supplement 1): 874.

https://doi.org/10.1182/blood-2023-186802

Published: 2023

Journal Articles

Comprehensive Genomic Characterization of Response and Resistance to Daratumumab-Based Quadruplet Induction in Newly Diagnosed Multiple Myeloma Patients

Blood (2023) 142 (Supplement 1): 3370.

https://doi.org/10.1182/blood-2023-187891

Published: 2023

Journal Articles

Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Neoplasms

Eli L. Diamond, Benjamin Durham, Ahmet Dogan, Mariko Yabe, Kseniya Petrova-Drus, Raajit K. Rampal, Raajit K. Rampal, Gary Ulaner, Mario Lacouture, Veronica Rotemberg, Anne Covey, Lynn Brody, Omar Abdel-Wahab

Blood (2023) 142 (Supplement 1): 1812.

https://doi.org/10.1182/blood-2023-187508

Published: 2023

Journal Articles

Genomic profiling for clinical decision making in lymphoid neoplasms

Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M. Horwitz, Ari M. Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano A. Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy B. Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L. King, Young H. Ko, Ann S. LaCasce, Georg Lenz, José I. Martin-Subero, Miguel A. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martinez, Scott J. Rodig, Andreas Rosenwald, Gilles A. Salles, Jesus San-Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier L. Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott

Blood (2022) 140 (21): 2193–2227.

https://doi.org/10.1182/blood.2022015854

Published: 2022

Includes: Supplemental data

Journal Articles

Erythroid and Megakaryocytic Differentiation Program in JAK2 -Mutated Acute Myeloid Leukemia with or without Antecedent Myeloproliferative Neoplasm

Blood (2022) 140 (Supplement 1): 9160–9162.

https://doi.org/10.1182/blood-2022-169215

Published: 2022

Journal Articles

Fc-Mediated Antibody Effector Function, Inflammation Resolution and Oligoclonality on TCR Rearrangements Predict Sustained MRD Negativity in Newly Diagnosed Multiple Myeloma Treated with Immunotherapy Regimens

Blood (2022) 140 (Supplement 1): 249–251.

https://doi.org/10.1182/blood-2022-165500

Published: 2022

Journal Articles

Tracking the Earliest Genomic Events in Multiple Myeloma Life-History

Blood (2022) 140 (Supplement 1): 1553–1555.

https://doi.org/10.1182/blood-2022-164742

Published: 2022

Journal Articles

LymphGen Classification of Diffuse Large B-Cell Lymphoma in a Cohort of Adolescent and Young Adult (AYA) Patients

Angelo Cabal, Menglei Zhu, Manik Uppal, Erel Joffe, Connie Lee Batlevi, Matthew J. Matasar, Michelle Okwali, Ahmet Dogan, Andrew D. Zelenetz, Gilles Salles, Niloufer Khan

Blood (2022) 140 (Supplement 1): 6392–6393.

https://doi.org/10.1182/blood-2022-162418

Published: 2022

NARROW

A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas

Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation

The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma

Deep Learning for Morphology-Based, Bone Marrow Cell Classification

Polytypic B-Cells, B-Cell Lymphoproliferative Disorders/Lymphomas, and Neoplastic T-Cells Divergently Differentiate from TET2 -/ DNMT3A -Mutated Clonal Hematopoiesis in Patients with Follicular Helper T-Cell Lymphomas/Lymphoproliferative Disorders

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

A Multicenter Phase 2 Trial of Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen) in Patients with Treatment-Naïve, TP53 -Mutant Mantle Cell Lymphoma

Impact of Early Histological Transformation on Survival in Patients with Follicular Lymphoma

Clinical Characteristics and Outcomes of Limited Stage High Grade B-Cell Lymphoma with MYC/BCL2 and/or BCL6 Rearrangements: A Single Center Experience

Cumulative Incidence of Myeloid Neoplasms in Patients with Nodal T-Follicular Helper Cell Lymphoma

Ruxolitinib Promotes Clinical Responses in Large Granular Lymphocytic Leukemia Via Suppression of JAK/STAT-Dependent Inflammatory Cascades

Real-World Outcomes in Patients with Transformed Follicular Lymphoma Treated with CD19-Targeting CAR-T Therapy

Revealing Novel Mechanisms Underlying Inactivation of Tumor Suppressor Genes on Duplicated Chromosomes in Multiple Myeloma

Comprehensive Genomic Characterization of Response and Resistance to Daratumumab-Based Quadruplet Induction in Newly Diagnosed Multiple Myeloma Patients

Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Neoplasms

Genomic profiling for clinical decision making in lymphoid neoplasms

Erythroid and Megakaryocytic Differentiation Program in JAK2 -Mutated Acute Myeloid Leukemia with or without Antecedent Myeloproliferative Neoplasm

Fc-Mediated Antibody Effector Function, Inflammation Resolution and Oligoclonality on TCR Rearrangements Predict Sustained MRD Negativity in Newly Diagnosed Multiple Myeloma Treated with Immunotherapy Regimens

Tracking the Earliest Genomic Events in Multiple Myeloma Life-History

LymphGen Classification of Diffuse Large B-Cell Lymphoma in a Cohort of Adolescent and Young Adult (AYA) Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only